RESUMEN
BACKGROUND: People who inject drugs (PWID) are the most important risk group for incident Hepatitis C virus (HCV) infection. In PWID in Europe HCV genotype 3a is highly prevalent. Unfortunately, many of the recently developed directly acting antiviral drugs against HCV (DAAs) are suboptimal for treatment of this genotype. Detection of resistance-associated variants (RAV) in genotype 3a may help to optimize treatment decisions, however, robust protocols for amplification and sequencing of HCV NS5A as an important target for treatment of genotype 3a are currently lacking. OBJECTIVES: The aim of this study was to establish a protocol for sequencing of HCV NS5A in genotype 3a and to determine the frequency of RAVs in treatment-naïve PWID living in Germany. STUDY DESIGN: The full NS5A region was amplified and sequenced from 110 HCV genotype 3a infected PWID using an in-house PCR protocol. RESULTS: With the established protocol the complete NS5A region was successfully amplified and sequenced from 110 out of 112 (98.2%) genotype 3a infected PWID. Phylogenetic analysis of sequences from PWID together with unrelated genotype 3a sequences from a public database showed a scattered distribution without geographic clustering. Viral polymorphisms A30K and Y93H known to confer resistance in a GT3a replication model were present in 8 subjects (7.2%). CONCLUSIONS: A protocol for amplification of nearly all GT3a samples was successfully established. Substitutions conferring resistance to NS5A inhibitors were detected in a few treatment-naive PWID.
Asunto(s)
Farmacorresistencia Viral , Consumidores de Drogas , Genotipo , Hepacivirus/efectos de los fármacos , Hepacivirus/genética , Hepatitis C/epidemiología , Hepatitis C/virología , Proteínas no Estructurales Virales/genética , Femenino , Variación Genética , Alemania/epidemiología , Hepacivirus/clasificación , Humanos , Masculino , Filogenia , Prevalencia , Vigilancia en Salud Pública , Análisis de Secuencia de ADNRESUMEN
BACKGROUND & AIMS: Despite continuous high-risk behavior, a subgroup among people who inject drugs (PWID) remains seronegative for hepatitis C virus (HCV) suggesting that a state of "natural resistance" to HCV Infection may exist. Homozygosity for KIR2DL3 and its ligand HLA-C1 group alleles has been associated with control of HCV infection, however, the mechanism mediating this protective effect remained unclear. METHODS: Peripheral NK cells from PWID (n=104) were phenotypically and functionally characterized by multicolor flow cytometry. Expression levels of the NK cell receptor ligands were analysed in liver biopsies and primary human hepatocytes. RESULTS: HCV seronegative PWID (n=34) had increased levels of KIR2DL3(+)NKG2A(-) NK cells compared to healthy controls (n=10; p<0.001) and PWID with chronic (n=38; p<0.001) or resolved infection (n=37; p<0.001). There was an inverse correlation between the frequency of KIR2DL3(+) and NKG2A(+) NK cells (r=-0.53; p<0.0001). Importantly, expression of HLA-E, the ligand for NKG2A, was significantly upregulated in liver biopsies of HCV infected patients (n=51) compared to HBV infected patients (n=22; p<0.01) and correlated with HCV viral load (r=0.32; p<0.0029). In functional analyses KIR2DL3(-)NKG2A(+) NK cells but not KIR2DL3(+)NKG2A(-) NK cells were significantly inhibited by HLA-E ligation. Accordingly, interferon gamma secretion of NK cells from PWID with chronic infection but not from HCV seronegative PWID was significantly suppressed in the presence of HLA-E. CONCLUSIONS: KIR2DL3(+)NKG2A(-) NK cells are not sensitive to HLA-E-mediated inhibition and may thereby control early HCV infection prior to seroconversion and result in an apparent state of "natural resistance" to HCV in PWID.
Asunto(s)
Hepacivirus , Hepatitis C/prevención & control , Inmunidad Innata , Células Asesinas Naturales/metabolismo , Células Asesinas Naturales/patología , Subfamília C de Receptores Similares a Lectina de Células NK/deficiencia , Receptores KIR2DL3/metabolismo , Abuso de Sustancias por Vía Intravenosa , Adulto , Alelos , Biopsia , Estudios de Casos y Controles , Femenino , Hepacivirus/fisiología , Hepatitis C/metabolismo , Hepatitis C/patología , Antígenos de Histocompatibilidad Clase I/metabolismo , Homocigoto , Humanos , Hígado/patología , Masculino , Fenotipo , Asunción de Riesgos , Replicación Viral , Antígenos HLA-ERESUMEN
OBJECTIVES: The recent emergence of new psychoactive compounds (novel psychoactive substances (NPS)) has raised prominent challenges in the fields of drug policy, substance use research, public health and service provision. The Recreational Drugs European Network project, funded by the European Commission, was implemented to improve the information stream to young people and professionals about effects/risks of NPS by identifying online products and disseminating relevant information through technological tools. METHODS: Regular multilingual qualitative assessments of websites, drugs fora and other online resources were carried out using the Google search engine in eight languages from collaborating countries. These included the following: the UK, Norway, Belgium, Germany, Hungary, Poland, Italy and Spain. Products were tested and prevention messages were developed and disseminated via technological tools such as interactive websites, SMS alert, social networking (Facebook, Twitter), Multimedia (You Tube), Smartphone applications (iPhone) and virtual learning environments (Second Life). RESULTS: The Recreational Drugs European Network project established itself as the first Europe-wide prevention programme designed for NPS based on the efficacy of novel information and communication technology-based forms of intervention. More than 650 NPS products and combinations were identified; relevant information was disseminated to target population and advice was given to both European Union/international agencies and national policy makers. CONCLUSIONS: Web-monitoring activities are essential for mapping the diffusion of NPS and the use of technological tools can be successfully incorporated in specific prevention programmes. Furthermore, the involvement of multi-disciplinary international partnerships was and continues to be fundamental for responding to such a prominent challenge.
Asunto(s)
Unión Europea/organización & administración , Servicios de Información/organización & administración , Cooperación Internacional , Internet/organización & administración , Psicotrópicos/efectos adversos , Bases de Datos Factuales/normas , Humanos , Drogas Ilícitas/efectos adversos , Drogas Ilícitas/química , Servicios de Información/normas , Internacionalidad , Internet/normas , Multilingüismo , Psicotrópicos/química , Factores de TiempoRESUMEN
BACKGROUND: This paper presents the outcomes of the 2-year European Union funded Psychonaut Web Mapping Project which aimed at developing and implementing an integrated web mapping system to promptly identify and learn about novel psychoactive substances (NPS; "legal highs") through the regular monitoring of the Internet. METHODS: More than 200 discussion forums, social media, online shops, websites and other Internet resources (e.g. YouTube, eBay, Google, Google Insight) have been extensively and regularly monitored in 7 European countries (UK, Finland, Norway, Belgium, Germany, Italy and Spain) for emerging trends of NPS throughout the period of the study. RESULTS: Key online resources have been identified as "leading edge" which have provided accurate and timely information on novel emerging compounds. In total more than 400 substances/products have been recorded. NPS have been noted online before reaching wider audiences. DISCUSSION: Although a high number of novel psychoactive substances have been identified in the 2-year duration of the project, not all have become trends that needed public health response. Conversely, new recreational drug phenomena such as "spice drugs," mephedrone and naphyrone were all identified as emerging trends in forums and websites. In addition, it has been possible for the first time to collate detailed information on these and several more compounds even though no or limited scientific publications were available. It is therefore recommended that these monitoring activities are to be continued, that more countries, researchers and health professionals are involved, and that the findings are widely shared with all the relevant agencies, health professionals and future research projects. Implications, advantages and limitations of using the Internet as primary source for identifying emerging trends are also discussed.
Asunto(s)
Monitoreo de Drogas/tendencias , Drogas Ilícitas , Internet/estadística & datos numéricos , Unión Europea , HumanosRESUMEN
On the basis of the material available both in the scientific literature and on the web, this paper aims to provide a pharmacological, chemical and behavioural overview of the novel compound methoxetamine. This is a dissociative drug related to ketamine, with a much longer duration of action and intensity of effects. A critical discussion of the availability of information on the web of methoxetamine as a new recreational trend is here provided. Those methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, are here discussed as well. It is concluded that the online availability of information on novel psychoactive drugs, such as methoxethanine, may constitute a pressing public health challenge. Better international collaboration levels and novel forms of intervention are necessary to tackle this fast-growing phenomenon.
Asunto(s)
Ciclohexanonas/farmacología , Ciclohexilaminas/farmacología , Drogas Ilícitas/farmacología , Internet , Ciclohexanonas/efectos adversos , Ciclohexanonas/farmacocinética , Ciclohexilaminas/efectos adversos , Ciclohexilaminas/farmacocinética , Drogas de Diseño/efectos adversos , Drogas de Diseño/farmacocinética , Drogas de Diseño/farmacología , Alucinógenos/efectos adversos , Alucinógenos/farmacocinética , Alucinógenos/farmacología , Humanos , Drogas Ilícitas/efectos adversos , Drogas Ilícitas/farmacocinética , Cooperación Internacional , Ketamina/farmacocinética , Ketamina/farmacología , Salud Pública , Trastornos Relacionados con Sustancias/epidemiología , Factores de TiempoRESUMEN
Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon.
Asunto(s)
Bromobenzoatos/efectos adversos , Drogas de Diseño/efectos adversos , Alucinógenos/efectos adversos , Drogas Ilícitas/efectos adversos , Internet , Propilaminas/efectos adversos , Control de Medicamentos y Narcóticos , Humanos , Salud PúblicaAsunto(s)
Aminas , Anticonvulsivantes , Clonazepam , Ácidos Ciclohexanocarboxílicos , Drogas Ilícitas , Trastornos Relacionados con Sustancias/diagnóstico , Ácido gamma-Aminobutírico/análogos & derivados , Aminas/efectos adversos , Anticonvulsivantes/efectos adversos , Clonazepam/efectos adversos , Estudios Transversales , Ácidos Ciclohexanocarboxílicos/efectos adversos , Relación Dosis-Respuesta a Droga , Vías de Administración de Medicamentos , Interacciones Farmacológicas , Control de Medicamentos y Narcóticos/legislación & jurisprudencia , Europa (Continente) , Gabapentina , Humanos , Drogas Ilícitas/efectos adversos , Pregabalina , Síndrome de Abstinencia a Sustancias/diagnóstico , Síndrome de Abstinencia a Sustancias/tratamiento farmacológico , Síndrome de Abstinencia a Sustancias/psicología , Trastornos Relacionados con Sustancias/epidemiología , Trastornos Relacionados con Sustancias/psicología , Ácido gamma-Aminobutírico/efectos adversosRESUMEN
BACKGROUND: Recently, those substances deriving from the active ingredient of the Khat plant, cathinone, have been rising in popularity. Indeed, 4-methylmethcathinone (mephedrone; 'meow meow' and others) has been seen by some as a cheaper alternative to other classified recreational drugs. AIMS: We aimed here at providing a state-of-the-art review on mephedrone history and prevalence of misuse, chemistry, pharmacology, legal status, product market appearance, clinical/management and related fatalities. METHODS: Because of the limited evidence, some of the information here presented has been obtained from user reports/drug user-orientated web sites. The most common routes for mephedrone recreational use include insufflation and oral ingestion. It elicits stimulant and empathogenic effects similar to amphetamine, methylamphetamine, cocaine and MDMA. Due to its sympathomimetic actions, mephedrone may be associated with a number of both physical and psychopathological side effects. Recent preliminary analysis of recent UK data carried out in 48 related cases have provided positive results for the presence of mephedrone at postmortem. DISCUSSION AND CONCLUSIONS: Within the UK, diffusion of mephedrone may have been associated with an unprecedented combination of a particularly aggressive online marketing policy and a decreasing availability/purity of both ecstasy and cocaine. Mephedrone has been recently classified in both the UK and in a number of other countries as a measure to control its availability. Following this, a few other research psychoactives have recently entered the online market as yet unregulated substances that may substitute for mephedrone. Only international collaborative efforts may be able to tackle the phenomenon of the regular offer of novel psychoactive drugs.
Asunto(s)
Drogas de Diseño , Metanfetamina/análogos & derivados , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Animales , Drogas de Diseño/efectos adversos , Drogas de Diseño/química , Drogas de Diseño/farmacología , Drogas de Diseño/uso terapéutico , Vías de Administración de Medicamentos , Humanos , Metanfetamina/efectos adversos , Metanfetamina/química , Metanfetamina/farmacología , Metanfetamina/uso terapéutico , Trastornos Relacionados con Sustancias/mortalidad , Trastornos Relacionados con Sustancias/prevención & controlRESUMEN
PURPOSE: Only a few formal assessments of websites with drug-related contents have been carried out. We aimed here at fostering collection and analysis of data from web pages related to information on consumption, manufacture and sales of psychoactive substances. GENERAL METHODS: An 8-language, two-engine, assessment of the information available in a purposeful sample of 1633 unique websites was carried out. FINDINGS: A pro-drug and a harm reduction approach were evident, respectively, in 18% and 10% of websites accessed. About 1 in 10 websites offered either psychoactive compounds for sale or detailed data on drugs' synthesis/extraction procedures. Information on a number of psychoactive substances and on unusual drugs' combinations not found in the Medline was elicited. CONCLUSIONS: This represents the first review which is both comprehensive and multilingual of the online available information on psychoactive compounds. Health professionals may need to be aware of the web being a new drug resource for information and possibly purchase.